Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NH

NantHealth

$3.06

-0.11 (-3.47%)

16:24
08/09/18
08/09
16:24
08/09/18
16:24
Earnings
NantHealth reports Q2 EPS (10c), consensus (11c) »

Reports Q2 revenue $22M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$1.33

0.01 (0.76%)

, NH

NantHealth

$3.50

0.02 (0.57%)

09:10
06/07/18
06/07
09:10
06/07/18
09:10
Hot Stocks
CytRx's aldoxorubicin shows lack of cardiac toxicity in clinical trials »

CytRx highlighted…

CYTR

CytRx

$1.33

0.01 (0.76%)

NH

NantHealth

$3.50

0.02 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NH

NantHealth

$3.36

-0.06 (-1.75%)

14:20
06/03/18
06/03
14:20
06/03/18
14:20
Hot Stocks
NantHealth unveils Liquid GPS for blood-based tumor profiling, monitoring »

NantHealth unveiled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

NH

NantHealth

$3.52

0.015 (0.43%)

16:26
05/09/18
05/09
16:26
05/09/18
16:26
Earnings
NantHealth reports Q1 EPS (20c), consensus (12c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

NH

NantHealth

$3.39

0.13 (3.99%)

08:11
05/07/18
05/07
08:11
05/07/18
08:11
Hot Stocks
NantHealth, NantOmics announced data from study on accuracy of diagnosis »

NantHealth and NantOmics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

NH

NantHealth

$3.10

-0.1 (-3.13%)

17:25
03/16/18
03/16
17:25
03/16/18
17:25
Syndicate
Breaking Syndicate news story on NantHealth »

NantHealth files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NH

NantHealth

$3.17

-0.46 (-12.67%)

16:21
03/14/18
03/14
16:21
03/14/18
16:21
Earnings
NantHealth reports Q4 adjusted EPS (7c), consensus (14c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

TRNC

Symbol now TPCO

$18.10

0.02 (0.11%)

, NH

NantHealth

$3.02

0.07 (2.37%)

17:38
02/06/18
02/06
17:38
02/06/18
17:38
Periodicals
Tronc to sell L.A. Times to major shareholder, Washington Post reports »

Tronc (TRNC) is expected…

TRNC

Symbol now TPCO

$18.10

0.02 (0.11%)

NH

NantHealth

$3.02

0.07 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.